Welcome to our dedicated page for Intest news (Ticker: INTT), a resource for investors and traders seeking the latest updates and insights on Intest stock.
InTest Corporation reports developments as a global supplier of test and process technology solutions used in manufacturing and testing across semiconductor, Auto/EV, defense/aerospace, industrial, life sciences, and safety/security markets. Company updates commonly cover quarterly results, orders, backlog, gross margin, product mix, and demand across diversified end markets.
Recurring news also includes leadership and board changes, investor-conference participation, acquisition integration, and customer orders tied to businesses such as Alfamation. Product-focused updates describe functional test systems, thermal, mechanical, and electronic solutions, and initiatives to expand cross-business selling, manufacturing efficiency, supply-chain performance, and targeted market reach.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
inTEST Corporation (NYSE American: INTT) will release its first quarter 2023 financial results on May 5, 2023, before the market opens. A conference call will be held at 8:30 a.m. ET on the same day to discuss the results and the company’s strategies and outlook. The call will include a question-and-answer session. Investors can access the conference call via phone or the company’s website. A replay will be available from 11:30 a.m. ET that day until May 12, 2023. inTEST specializes in test and process solutions for various sectors including automotive, defense, and semiconductor manufacturing, leveraging a strong engineering background to drive growth and profitability.
inTEST Corporation (NYSE American: INTT) announced a partnership between its subsidiary, inTEST Thermal Solutions, and Stellar Scientific. This collaboration aims to distribute inTEST’s Ultra-Low Temperature (ULT) biomedical freezers, enhancing opportunities in the U.S. government market through Stellar's General Services Administration (GSA) contract. The North Sciences ULT freezers are crucial for preserving biomedical samples at -86°C, ensuring research integrity. Leaders from both companies expressed optimism about expanding their reach and offerings, particularly within the life sciences and defense sectors. This initiative aligns with inTEST's strategic focus on innovative solutions in critical temperature control.
inTEST Corporation (NYSE American: INTT) announced its participation in the Sidoti Small Cap Conference on March 23, 2023. The presentation will be led by Nick Grant, President & CEO, and Duncan Gilmour, CFO, starting at 10:00 a.m. Eastern Time. A live webcast, along with presentation materials, will be accessible on their investor relations website. inTEST specializes in innovative test and process solutions for various sectors, including automotive, defense, industrial, and semiconductor manufacturing.
inTEST Corporation (NYSE American: INTT) reported record fourth quarter revenue of $32.4 million, a 45% increase, and full year revenue of $116.8 million, up 38% compared to the prior year. Fourth quarter earnings per diluted share were $0.30, with $31.3 million in orders, marking a 3% increase. The company anticipates Q1 2023 revenue between $30 million and $32 million, and full year 2023 revenue of $125 million to $130 million. The growth was supported by strong demand in semiconductor, automotive, defense, and life sciences sectors, alongside successful integration of acquisitions.